ONVO
ONVO Real Time Price USDRecent trades of ONVO by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| William L. Owens House / D | Purchase $1,001 - $15,000 | Nov 06, 2014 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ONVO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$30,000 Jul 09, 2025 Issue: Health Issues
-
$10,000 Oct 17, 2023 Issue: None
-
$30,000 Jul 18, 2023 Issue: Health Issues
-
$30,000 Jan 19, 2023 Issue: Health Issues
-
$30,000 Oct 12, 2022 Issue: Health Issues
-
$30,000 Jul 18, 2022 Issue: Health Issues
-
$30,000 Apr 13, 2022 Issue: Health Issues
-
$20,000 Jan 13, 2022 Issue: Health Issues
-
$20,000 Apr 14, 2016 Issue: Health Issues
-
$20,000 Jan 13, 2016 Issue: Health Issues
-
$30,000 Oct 13, 2015 Issue: Health Issues
-
$10,000 Jul 14, 2015 Issue: Health Issues
-
$10,000 Apr 17, 2015 Issue: Health Issues
-
$20,000 Jan 20, 2015 Issue: Health Issues
Estimated quarterly lobbying spending
ONVO Revenue by Segment or Geography
New patents grants
-
Patent Title: Use of engineered liver tissue constructs for modeling liver disorders Mar. 18, 2025
-
Patent Title: Methods for tissue fabrication Jul. 16, 2024
-
Patent Title: Use of engineered renal tissues in assays May. 14, 2024
-
Patent Title: Engineered renal tissues, arrays thereof, and methods of making the same Jan. 09, 2024
-
Patent Title: Bioprinted hair follicles and uses thereof Dec. 26, 2023
-
Patent Title: Farnesoid x receptor agonists and uses thereof Oct. 03, 2023
-
Patent Title: Engineered intestinal tissue and uses thereof May. 23, 2023
-
Patent Title: Bioprinter for the fabrication of tissue Feb. 14, 2023
-
Patent Title: Methods for the fabrication of tissue via printing Feb. 14, 2023
-
Patent Title: Engineered three-dimensional skin tissues, arrays thereof, and methods of making the same Dec. 20, 2022
-
Patent Title: Bioprinter for the fabrication of tissue Aug. 16, 2022
-
Patent Title: Use of engineered renal tissues in assays Mar. 08, 2022
-
Patent Title: Engineered liver tissues, arrays thereof, and methods of making the same Sep. 21, 2021
-
Patent Title: Devices, systems, and methods for the fabrication of tissue Apr. 06, 2021
-
Patent Title: Engineered renal tissues, arrays thereof, and methods of making the same Mar. 30, 2021
-
Patent Title: Engineered liver tissues, arrays thereof, and methods of making the same Sep. 03, 2019
-
Patent Title: Devices, systems, and methods for the fabrication of tissue utilizing uv cross-linking Jan. 08, 2019
-
Patent Title: Engineered renal tissues, arrays thereof, and methods of making the same Oct. 09, 2018
-
Patent Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model May. 29, 2018
-
Patent Title: Method of printing a three-dimensional structure Jan. 02, 2018
-
Patent Title: Devices, systems, and methods for the fabrication of tissue utilizing uv cross-linking Nov. 22, 2016
-
Patent Title: Engineered renal tissues, arrays thereof, and methods of making the same Nov. 01, 2016
-
Patent Title: Engineered liver tissues, arrays thereof, and methods of making the same Sep. 13, 2016
-
Patent Title: Automated devices, systems, and methods for the fabrication of tissue Apr. 19, 2016
-
Patent Title: Devices, systems, and methods for the fabrication of tissue Jan. 05, 2016
-
Patent Title: Engineered liver tissues, arrays thereof, and methods of making the same Dec. 29, 2015
-
Patent Title: Devices, systems, and methods for the fabrication of tissue Oct. 06, 2015
-
Patent Title: Devices, systems, and methods for the fabrication of tissue Jan. 13, 2015
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ONVO
Recent picks made for ONVO stock on CNBC
ETFs with the largest estimated holdings in ONVO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ONVO stock a Buy, Sell, or Hold?
- What is the price target for $ONVO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ONVO stock?
- Who owns the most shares of $ONVO stock?
- What funds own $ONVO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ONVO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.